P. Darken

发表论文 110 篇 · 总被引 2631 次 · h-index 22

代表论文

Treatment Trials in Pre-COPD and Young COPD: Time to Move Forward. (2021 · American Journal of Respiratory and Critical Care Medicine · 被引 54)
Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial (2021 · Therapeutic Advances in Respiratory Disease · 被引 29)
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS (2022 · International Journal of COPD · 被引 25)
Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial. (2021 · Respiratory Medicine · 被引 24)
Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS (2021 · International Journal of COPD · 被引 17)
Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT (2023 · Current Medical Research and Opinion · 被引 12)